Abstract
Aim: Spinal cord injury (SCI) can cause severe disability. Several clinical trials of stem-cell based therapies are ongoing. We describe our experience of bone marrow mesenchymal stem cell (BMSC) therapy in a patient with complete SCI in the chronic stage. Case report: A 25-year-old man with complete SCI at T6 level presented with paraplegia for 5 years. We transplanted autologous BMSCs intramedullary. After 12 months follow-up, his Barthel index score was noticeably improved from severe to moderate dependency, and the sensation level improved from T7 to S5, but no improvement of motor function. Conclusion: Autologous BMSCs are potentially safe for patients with complete SCI in the chronic stage and may improve neurological function and quality of life.
Papers of special note have been highlighted as: • of interest
References
- 1. The influence of time from injury to surgery on motor recovery and length of hospital stay in acute traumatic spinal cord injury: an observational Canadian cohort study. J. Neurotrauma 32(9), 645–654 (2015).
- 2. . Emerging therapies for acute traumatic spinal cord injury. CMAJ 185(6), 485–492 (2013).
- 3. . From basics to clinical: a comprehensive review on spinal cord injury. Prog. Neurobiol. 114, 25–57 (2014).
- 4. . Current status of acute spinal cord injury pathophysiology and emerging therapies: promise on the horizon. Neurosurg. Focus. 25(5), E2 (2008).
- 5. . Spinal-cord injury. Lancet (London, England). 359(9304), 417–425 (2002).
- 6. . Approaches to repairing the damaged spinal cord: overview. Handb. Clinic. Neurol. 109, 445–461 (2012).
- 7. Different functional bio-scaffolds share similar neurological mechanism to promote locomotor recovery of canines with complete spinal cord injury. Biomaterials 214, 119230 (2019).
- 8. . Scarring after spinal cord injury. J. Neurosurg. Spine 13(2), 165–167; discussion 167–168 (2010).
- 9. Transplants and neurotrophic factors increase regeneration and recovery of function after spinal cord injury. Prog. Brain Res. 137, 257–273 (2002).
- 10. . Mesenchymal stem cells from rat bone marrow downregulate caspase-3-mediated apoptotic pathway after spinal cord injury in rats. Neurochem. Res. 32(12), 2080–2093 (2007).
- 11. . Influence of sexuality in functional recovery after spinal cord injury in rats. Arch. Bone Joint Surg. 4(1), 56–59 (2016).
- 12. Endothelial progenitors: a consensus statement on nomenclature. Stem Cells Translati. Med. 6(5), 1316–1320 (2017).
- 13. . Future directions for using estrogen receptor agonists in the treatment of acute and chronic spinal cord injury. Neur. Regen. Res. 11(9), 1418–1419 (2016).
- 14. . Identification of patients with cervical SCI suitable for early nerve transfer to achieve hand opening. Spinal Cord 55(2), 131–134 (2017).
- 15. . Current concept of stem cell therapy for spinal cord injury: a review. Korean J. Neurotr. 12(2), 40–46 (2016).
- 16. . Current options for drug delivery to the spinal cord. Exp. Opin. Drug Deliv. 10(3), 385–396 (2013).
- 17. Repetitive intrathecal catheter delivery of bone marrow mesenchymal stromal cells improves functional recovery in a rat model of contusive spinal cord injury. J. Neurotrauma 28(9), 1951–1961 (2011).
- 18. . Mesenchymal stem cell-derived exosomes: therapeutic opportunities and challenges for spinal cord injury. Stem Cell Res. Ther. 12(1), 102 (2021). • Exosomes arising from mesenchymal stem cells provide affable functions, through intravenous injection in the rat mode, such as to inhibit A1 astrocytes, to enhance axonal regeneration, to shift macrophage to M2 subtype, and to protect the blood–spinal cord barrier.
- 19. Growth factor gene-modified cells in spinal cord injury recovery: a systematic review. World Neurosurg. 162, 150–162.e151 (2022). • One of the major concerns is safety about that gene-modified therapy by using viral genome, which might induce genetic aberration and teratoma formation.
- 20. . Strategies for effective neural circuit reconstruction after spinal cord injury: use of stem cells and biomaterials. World Neurosurg. 161, 82–89 (2022). • With the improvement of 3D bioprinting technology, personalized bionic functional scaffolds can be created with accurately and efficiently complex microenvironment to restore or repair spinal cord structure.
- 21. . The application of 3D-bioprinted scaffolds for neuronal regeneration after traumatic spinal cord injury – a systematic review of preclinical in vivo studies. Exp. Neurol. 363, 114366 (2023).